Chinares Pharma (03320) announced interim results
- RevenueRMB1344.6bn
- Net profitRMB50.2bn
- Profit attributable to ownersRMB21.9bn
- Revenue YoY+2.0%
- Net profit YoY-0.6%
- Depreciation & amortisationHK$40.8bn
- Capital expenditureHK$-35.5bn
- Interest-bearing debtHK$600.4bn
Source Chinares Pharma



